Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-16

Clinical Trial Update: Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether adding N-acetylcysteine to amiodarone, or amiodarone alone, prevents atrial fibrillation after thoracic surgery; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Thoracic Surgery, Atrial Fibrillation in High Risk Patients | Phase 3 | Status: ACTIVE_NOT_RECRUITING